933
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Microwave ablation is effective against liver metastases from gastric adenocarcinoma

, , , , , , & show all
Pages 830-835 | Received 16 Jan 2017, Accepted 09 Mar 2017, Published online: 29 Mar 2017

References

  • Ferlay J, Soerjomataram I, Dikshit R, et al. (2015). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–86.
  • Hwang JE, Kim SH, Jin J, et al. (2014). Combination of percutaneous radiofrequency ablation and systemic chemotherapy are effective treatment modalities for metachronous liver metastases from gastric cancer. Clin Exp Metastases 31:25–32.
  • Komeda K, Hayashi M, Kubo S, et al. (2014). High survival in patients operated for small isolated liver metastases from gastric cancer: a multi-institutional study. World J Surg 38:2692–7.
  • Kakeji Y, Morita M, Maehara Y. (2010). Strategies for treating liver metastasis from gastric cancer. Surg Today 40:287–94.
  • Lordick F, Kang YK, Chung HC, et al. (2013). Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial. Lancet Oncol 14:490–9.
  • Vogl TJ, Gruber-Rouh T, Eichler K, et al. (2013). Repetitive transarterial chemoembolization (TACE) of liver metastases from gastric cancer: local control and survival results. Eur J Radiol 82:258–63.
  • Yoshida M, Ohtsu A, Boku N, et al. (2004). Long-term survival and prognostic factors in patients with metastatic gastric cancers treated with chemotherapy in the Japan Clinical Oncology Group (JCOG) study. Jpn J Clin Oncol 34:654–9.
  • Li D, Kang J, Madoff DC. (2014). Locally ablative therapies for primary and metastatic liver cancer. Expert Rev Anticancer Ther 14:931–45.
  • Stang A, Oldhafer KJ, Weilert H, et al. (2014). Selection criteria for radiofrequency ablation for colorectal liver metastases in the era of effective systemic therapy: a clinical score based proposal. BMC Cancer 14:500.
  • Aliyev S, Agcaoglu O, Aksoy E, et al. (2013). Efficacy of laparoscopic radiofrequency ablation for the treatment of patients with small solitary colorectal liver metastases. Surgery 154:556–62.
  • Agcaoglu O, Aliyev S, Karabulut K, et al. (2013). Complementary use of resection and radiofrequency ablation for the treatment of colorectal liver metastases: an analysis of 395 patients. World J Surg 37:1333–9.
  • Kim HR, Cheon SH, Lee KH, et al. (2010). Efficacy and feasibility of radiofrequency ablation for liver metastases from gastric adenocarcinoma. Int J Hyperthermia 26:305–15.
  • Chen J, Tang Z, Dong X, et al. (2013). Radiofrequency ablation for liver metastasis from gastric cancer. Eur J Surg Oncol 39:701–6.
  • Leung U, Kuk D, D'Angelica MI, et al. (2015). Long-term outcomes following microwave ablation for liver malignancies. Br J Surg 102:85–91.
  • Engstrand J, Nilsson H, Jansson A, et al. (2014). A multiple microwave ablation strategy in patients with initially unresectable colorectal cancer liver metastases – a safety and feasibility study of a new concept. Eur J Surg Oncol 40:1488–93.
  • Pathak S, Jones R, Tang JM, et al. (2011). Ablative therapies for colorectal liver metastases: a systematic review. Colorectal Dis 13:e252–65.
  • Vogl TJ, Farshid P, Naguib NN, et al. (2014). Thermal ablation of liver metastases from colorectal cancer: radiofrequency, microwave and laser ablation therapies. Radiol Med 119:451–61.
  • Correa-Gallego C, Fong Y, Gonen M, et al. (2014). A retrospective comparison of microwave ablation vs. radiofrequency ablation for colorectal cancer hepatic metastases. Ann Surg Oncol 21:4278–83.
  • Liu F, Yu X, Liang P, et al. (2011). Contrast-enhanced ultrasound-guided microwave ablation for hepatocellular carcinoma inconspicuous on conventional ultrasound. Int J Hyperthermia 27:555–62.
  • Liang P, Wang Y, Yu X, Dong B. (2009). Malignant liver tumors: treatment with percutaneous microwave ablation-complications among cohort of 1136 patients. Radiology 251:933–40.
  • Ahmed M, Solbiati L, Brace CL, et al. (2014). Image-guided tumor ablation: standardization of terminology and reporting criteria – a 10-year update. Radiology 273:241–60.
  • Siegel R, Naishadham D, Jemal A. (2013). Cancer statistics, 2013. CA Cancer J Clin 63:11–30.
  • Wang W, Liang H, Zhang H, et al. (2014). Prognostic significance of radical surgical treatment for gastric cancer patients with synchronous liver metastases. Med Oncol 31:258.
  • Kinoshita T, Saiura A, Esaki M, et al. (2015). Multicentre analysis of long-term outcome after surgical resection for gastric cancer liver metastases. Br J Surg 102:102–7.
  • Takemura N, Saiura A, Koga R, et al. (2012). Long-term outcomes after surgical resection for gastric cancer liver metastases: an analysis of 64 macroscopically complete resections. Langenbecks Arch Surg 397:951–7.
  • Liu C, Wang Y, Yu X, et al. (2011). Is percutaneous microwave ablation of liver tumor safe for patients with renal dysfunction. Eur J Radiol 79:e103–7.
  • Minami Y, Kudo M. (2013). Radiofrequency ablation of liver metastases from colorectal cancer: a literature review. Gut Liver 7:1–6.
  • Oki E, Tokunaga S, Emi Y, et al. (2016). Surgical treatment of liver metastases of gastric cancer: a retrospective multicenter cohort study (KSCC 1302). Gastric Cancer 19:968–76.
  • Guner A, Son T, Cho I, et al. (2016). Liver-directed treatments for liver metastases from gastric adenocarcinoma: comparison between liver resection and radiofrequency ablation. Gastric Cancer 19:951–60.
  • Lee CW, Kim JH, Won HJ, et al. (2015). Percutaneous radiofrequency ablation of hepatic metastases from gastric adenocarcinoma after hysterectomy. J Vasc Interv Radiol 26:1172–9.
  • Kim HO, Hwang SI, Hong HP, Yoo CH. (2009). Radiofrequency ablation for metachronous hepatic metastases from gastric cancer. Surg Laparosc Endosc Percutan Tech 19:208–12.
  • An JY, Kim JY, Choi MG, et al. (2008). Radiofrequency ablation for hepatic metastasis from gastric adenocarcinoma. Yonsei Med J 49:1046–51.
  • Yamakado K, Nakatsuka A, Takaki H, et al. (2005). Prospective study of arterial infusion chemotherapy followed by radiofrequency ablation for the treatment of liver metastases of gastric cancer. J Vasc Interv Radiol 16:1747–51.
  • Yamakado K. (2014). Image-guided ablation of adrenal lesions. Semin Intervent Radiol 31:149–56.
  • Gannon CJ, Curley SA. (2005). The role of focal liver ablation in the treatment of unresectable primary and secondary malignant liver tumors. Semin Radiat Oncol 15:265–72.
  • Shinohara T, Maeda Y, Hamada T, Futakawa N. (2015). Survival benefit of surgical treatment for liver metastases from gastric cancer. J Gastrointest Surg 19:1043–51.
  • Cheon SH, Rha SY, Jeung HC, et al. (2008). Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases. Ann Oncol 19:1146–53.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.